Compare FFBC & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FFBC | HTFL |
|---|---|---|
| Founded | 1863 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2004 | N/A |
| Metric | FFBC | HTFL |
|---|---|---|
| Price | $30.16 | $29.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $30.71 | ★ $38.20 |
| AVG Volume (30 Days) | 707.4K | ★ 964.6K |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | ★ 10.83 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.67 | $27.66 |
| Revenue Next Year | $4.58 | $23.55 |
| P/E Ratio | $11.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.94 | $20.13 |
| 52 Week High | $31.38 | $41.22 |
| Indicator | FFBC | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 52.88 |
| Support Level | $28.80 | $28.60 |
| Resistance Level | $31.30 | $32.81 |
| Average True Range (ATR) | 0.66 | 1.55 |
| MACD | -0.05 | -0.28 |
| Stochastic Oscillator | 48.89 | 28.73 |
First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.